Edwin J Yoo1, Gaoyuan Cao1, Cynthia J Koziol-White1, Christie A Ojiaku1, Krishna Sunder1, Joseph A Jude1, James V Michael2, Hong Lam3, Ivan Pushkarsky4, Robert Damoiseaux5,6, Dino Di Carlo4,6,7, Kwangmi Ahn8, Steven S An3,9, Raymond B Penn2, Reynold A Panettieri1. 1. Rutgers Institute for Translational Medicine and Science, Child Health Institute, Rutgers University, New Brunswick, NJ, USA. 2. Department of Medicine, Division of Pulmonary and Critical Care Medicine, Center for Translational Medicine, Jane and Leonard Korman Lung Center, Thomas Jefferson University, Philadelphia, PA, USA. 3. Department of Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 4. Department of Bioengineering, University of California, Los Angeles, CA, USA. 5. Department of Molecular and Medicinal Pharmacology, University of California, Los Angeles, CA, USA. 6. California NanoSystems Institute, University of California, Los Angeles, CA, USA. 7. Department of Mechanical Engineering, University of California, Los Angeles, CA, USA. 8. National Institute of Mental Health, Bethesda, MD, USA. 9. Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA.
Abstract
BACKGROUND AND PURPOSE: PI3K-dependent activation of Rho kinase (ROCK) is necessary for agonist-induced human airway smooth muscle cell (HASMC) contraction, and inhibition of PI3K promotes bronchodilation of human small airways. The mechanisms driving agonist-mediated PI3K/ROCK axis activation, however, remain unclear. Given that G12 family proteins activate ROCK pathways in other cell types, their role in M3 muscarinic acetylcholine receptor-stimulated PI3K/ROCK activation and contraction was examined. EXPERIMENTAL APPROACH: Gα12 coupling was evaluated using co-immunoprecipitation and serum response element (SRE)-luciferase reporter assays. siRNA and pharmacological approaches, as well as overexpression of a regulator of G-protein signaling (RGS) proteins were applied in HASMCs. Phosphorylation levels of Akt, myosin phosphatase targeting subunit-1 (MYPT1), and myosin light chain-20 (MLC) were measured. Contraction and shortening were evaluated using magnetic twisting cytometry (MTC) and micro-pattern deformation, respectively. Human precision-cut lung slices (hPCLS) were utilized to evaluate bronchoconstriction. KEY RESULTS: Knockdown of M3 receptors or Gα12 attenuated activation of Akt, MYPT1, and MLC phosphorylation. Gα12 coimmunoprecipitated with M3 receptors, and p115RhoGEF-RGS overexpression inhibited carbachol-mediated induction of SRE-luciferase reporter. p115RhoGEF-RGS overexpression inhibited carbachol-induced activation of Akt, HASMC contraction, and shortening. Moreover, inhibition of RhoA blunted activation of PI3K. Lastly, RhoA inhibitors induced dilation of hPCLS. CONCLUSIONS AND IMPLICATIONS: Gα12 plays a crucial role in HASMC contraction via RhoA-dependent activation of the PI3K/ROCK axis. Inhibition of RhoA activation induces bronchodilation in hPCLS, and targeting Gα12 signaling may elucidate novel therapeutic targets in asthma. These findings provide alternative approaches to the clinical management of airway obstruction in asthma.
BACKGROUND AND PURPOSE: PI3K-dependent activation of Rho kinase (ROCK) is necessary for agonist-induced human airway smooth muscle cell (HASMC) contraction, and inhibition of PI3K promotes bronchodilation of human small airways. The mechanisms driving agonist-mediated PI3K/ROCK axis activation, however, remain unclear. Given that G12 family proteins activate ROCK pathways in other cell types, their role in M3 muscarinic acetylcholine receptor-stimulated PI3K/ROCK activation and contraction was examined. EXPERIMENTAL APPROACH: Gα12 coupling was evaluated using co-immunoprecipitation and serum response element (SRE)-luciferase reporter assays. siRNA and pharmacological approaches, as well as overexpression of a regulator of G-protein signaling (RGS) proteins were applied in HASMCs. Phosphorylation levels of Akt, myosin phosphatase targeting subunit-1 (MYPT1), and myosin light chain-20 (MLC) were measured. Contraction and shortening were evaluated using magnetic twisting cytometry (MTC) and micro-pattern deformation, respectively. Human precision-cut lung slices (hPCLS) were utilized to evaluate bronchoconstriction. KEY RESULTS: Knockdown of M3 receptors or Gα12 attenuated activation of Akt, MYPT1, and MLC phosphorylation. Gα12 coimmunoprecipitated with M3 receptors, and p115RhoGEF-RGS overexpression inhibited carbachol-mediated induction of SRE-luciferase reporter. p115RhoGEF-RGS overexpression inhibited carbachol-induced activation of Akt, HASMC contraction, and shortening. Moreover, inhibition of RhoA blunted activation of PI3K. Lastly, RhoA inhibitors induced dilation of hPCLS. CONCLUSIONS AND IMPLICATIONS: Gα12 plays a crucial role in HASMC contraction via RhoA-dependent activation of the PI3K/ROCK axis. Inhibition of RhoA activation induces bronchodilation in hPCLS, and targeting Gα12 signaling may elucidate novel therapeutic targets in asthma. These findings provide alternative approaches to the clinical management of airway obstruction in asthma.
Authors: R A van Nieuwstadt; P A Henricks; R Hajer; W A van der Meer van Roomen; H J Breukink; F P Nijkamp Journal: Vet Q Date: 1997-06 Impact factor: 3.320
Authors: Xun Shang; Fillipo Marchioni; Nisha Sipes; Chris R Evelyn; Moran Jerabek-Willemsen; Stefan Duhr; William Seibel; Matthew Wortman; Yi Zheng Journal: Chem Biol Date: 2012-06-22
Authors: Stephen Ph Alexander; Anthony P Davenport; Eamonn Kelly; Neil Marrion; John A Peters; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies Journal: Br J Pharmacol Date: 2015-12 Impact factor: 8.739
Authors: Edwin J Yoo; Gaoyuan Cao; Cynthia J Koziol-White; Christie A Ojiaku; Krishna Sunder; Joseph A Jude; James V Michael; Hong Lam; Ivan Pushkarsky; Robert Damoiseaux; Dino Di Carlo; Kwangmi Ahn; Steven S An; Raymond B Penn; Reynold A Panettieri Journal: Br J Pharmacol Date: 2017-11-12 Impact factor: 8.739
Authors: Joseph A Jude; Krishnaswamy G Tirumurugaan; Bit Na Kang; Reynold A Panettieri; Timothy F Walseth; Mathur S Kannan Journal: Am J Respir Cell Mol Biol Date: 2012-05-03 Impact factor: 6.914
Authors: Yasin Shaifta; Nneka Irechukwu; Jesus Prieto-Lloret; Charles E MacKay; Keisha A Marchon; Jeremy P T Ward; Greg A Knock Journal: Br J Pharmacol Date: 2015-10-23 Impact factor: 8.739
Authors: Christie A Ojiaku; Elena Chung; Vishal Parikh; Jazmean K Williams; Anthony Schwab; Ana Lucia Fuentes; Maia L Corpuz; Victoria Lui; Sam Paek; Natalia M Bexiga; Shreya Narayan; Francisco J Nunez; Kwangmi Ahn; Rennolds S Ostrom; Steven S An; Reynold A Panettieri Journal: Am J Respir Cell Mol Biol Date: 2019-08 Impact factor: 6.914
Authors: Edwin J Yoo; Gaoyuan Cao; Cynthia J Koziol-White; Christie A Ojiaku; Krishna Sunder; Joseph A Jude; James V Michael; Hong Lam; Ivan Pushkarsky; Robert Damoiseaux; Dino Di Carlo; Kwangmi Ahn; Steven S An; Raymond B Penn; Reynold A Panettieri Journal: Br J Pharmacol Date: 2017-11-12 Impact factor: 8.739
Authors: Ivan Pushkarsky; Peter Tseng; Dylan Black; Bryan France; Lyndon Warfe; Cynthia J Koziol-White; William F Jester; Ryan K Trinh; Jonathan Lin; Philip O Scumpia; Sherie L Morrison; Reynold A Panettieri; Robert Damoiseaux; Dino Di Carlo Journal: Nat Biomed Eng Date: 2018-02-06 Impact factor: 25.671
Authors: Sarah Orfanos; Joseph Jude; Brian T Deeney; Gaoyuan Cao; Deepa Rastogi; Mark van Zee; Ivan Pushkarsky; Hector E Munoz; Robert Damoiseaux; Dino Di Carlo; Reynold A Panettieri Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-08-30 Impact factor: 5.464
Authors: Pawan Sharma; Santosh K Yadav; Sushrut D Shah; Elham Javed; John M Lim; Shi Pan; Ajay P Nayak; Reynold A Panettieri; Raymond B Penn; Taku Kambayashi; Deepak A Deshpande Journal: Am J Respir Cell Mol Biol Date: 2021-12 Impact factor: 6.914
Authors: Ajay P Nayak; John M Lim; Eylon Arbel; Ruping Wang; Dominic R Villalba; Tahn L Nguyen; Niccole Schaible; Ramaswamy Krishnan; Dale D Tang; Raymond B Penn Journal: FASEB J Date: 2021-07 Impact factor: 5.834